TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

Launched by NOVOCURE LTD. · Sep 9, 2022

Keywords

ClinConnect Summary

This clinical trial, called the TTFields in General Routine Clinical Care in Patients with Pleural Mesothelioma Study, is looking at how effective a treatment called Tumor Treating Fields (TTFields) is for patients with pleural mesothelioma, a type of cancer that affects the lining of the lungs. The goal is to gather real-world information on how TTFields is used in everyday clinical practice. Patients who are 18 years or older, have been diagnosed with pleural mesothelioma, and have no chance for surgery to cure their cancer may be eligible to participate. They must also expect to live for at least three more months and agree to allow their data to be used for research.

If you join the study, you will receive the TTFields treatment as part of your normal care. This trial is currently recruiting participants from all backgrounds and genders, and it aims to help doctors better understand how this treatment works in regular clinical settings. It's important to note that those who have already received TTFields treatment for more than one week will not be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥ 18 years of age
• • Histologically confirmed pleural mesothelioma without any option of curative resection
• • Planned treatment with NovoTTF-200T System according to IFU and medical guidelines
• • Life expectancy more than 3 months at day of enrollment
• • Signed informed consent for use and processing of data
• Exclusion Criteria:
• • • Previous treatment with NovoTTF-200T for more than 1 week at day of enrollment